MONITORING AND DEFIBRILLATION SYSTEM LIFEPACK 12 - LIFEPACK 20 DEFIBRILLATOR AND LIFEPACK 9P MONITORING AND DEFIBRILLATION SYSTEM - Registered at ANVISA under the numbers 10339190080 - 10339191171 and 10339190082 - respectively. LOTS AFFECTED - according to the list attached to this Alert. http://en.wikipedia.org/w/index.php??

제조사

  • 제조사 모회사 (2017)
  • 제조사 의견
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    ANVSANVISA